pharmaceuticals-and-healthcare

United States Radiopharmaceuticals Market Report 2017


Published On : Aug 2017

Category : Pharmaceutical

No. of Pages : 107 pages

  • $3800
  • $7600

Please click below to avail discount on this report

In this report, the United States Radiopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Radiopharmaceuticals in these regions, from 2012 to 2022 (forecast).

United States Radiopharmaceuticals market competition by top manufacturers/players, with Radiopharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diagnostic Radioisotopes
Therapeutic Radioisotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Radiopharmaceuticals for each application, including
Oncology
Cardiology
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

In the recent times, the global market for United states radiopharmaceuticals market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of United states radiopharmaceuticals market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the United states radiopharmaceuticals market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the United states radiopharmaceuticals market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of United states radiopharmaceuticals market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for United states radiopharmaceuticals market report 2017, including the definition, classification, and industry chain structure of United states radiopharmaceuticals market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the United states radiopharmaceuticals market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for United states radiopharmaceuticals market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning United states radiopharmaceuticals market report 2017, implemented in each of the geographical segments. The predominant applications of the United states radiopharmaceuticals market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for United states radiopharmaceuticals market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the United states radiopharmaceuticals market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Radiopharmaceuticals
Figure United States Radiopharmaceuticals Market Size (K Doses) by Type (2012-2022)
Figure United States Radiopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Radioisotopes Product Picture
Figure Therapeutic Radioisotopes Product Picture
Figure United States Radiopharmaceuticals Market Size (K Doses) by Application (2012-2022)
Figure United States Sales Market Share of Radiopharmaceuticals by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Radiopharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure The West Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Radiopharmaceuticals Sales (K Doses) and Growth Rate (2012-2022)
Figure United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Radiopharmaceuticals Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table United States Radiopharmaceuticals Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table United States Radiopharmaceuticals Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Radiopharmaceuticals Sales Share by Players/Suppliers
Figure 2017 United States Radiopharmaceuticals Sales Share by Players/Suppliers
Figure United States Radiopharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Radiopharmaceuticals Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Radiopharmaceuticals Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Radiopharmaceuticals Revenue Share by Players/Suppliers
Figure 2017 United States Radiopharmaceuticals Revenue Share by Players/Suppliers
Table United States Market Radiopharmaceuticals Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)
Figure United States Market Radiopharmaceuticals Average Price (USD/Dose) of Key Players/Suppliers in 2016
Figure United States Radiopharmaceuticals Market Share of Top 3 Players/Suppliers
Figure United States Radiopharmaceuticals Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Radiopharmaceuticals Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Radiopharmaceuticals Product Category
Table United States Radiopharmaceuticals Sales (K Doses) by Region (2012-2017)
Table United States Radiopharmaceuticals Sales Share by Region (2012-2017)
Figure United States Radiopharmaceuticals Sales Share by Region (2012-2017)
Figure United States Radiopharmaceuticals Sales Market Share by Region in 2016
Table United States Radiopharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Radiopharmaceuticals Revenue Share by Region (2012-2017)
Figure United States Radiopharmaceuticals Revenue Market Share by Region (2012-2017)
Figure United States Radiopharmaceuticals Revenue Market Share by Region in 2016
Table United States Radiopharmaceuticals Price (USD/Dose) by Region (2012-2017)
Table United States Radiopharmaceuticals Sales (K Doses) by Type (2012-2017)
Table United States Radiopharmaceuticals Sales Share by Type (2012-2017)
Figure United States Radiopharmaceuticals Sales Share by Type (2012-2017)
Figure United States Radiopharmaceuticals Sales Market Share by Type in 2016
Table United States Radiopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Radiopharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals by Type (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals by Type in 2016
Table United States Radiopharmaceuticals Price (USD/Dose) by Types (2012-2017)
Figure United States Radiopharmaceuticals Sales Growth Rate by Type (2012-2017)
Table United States Radiopharmaceuticals Sales (K Doses) by Application (2012-2017)
Table United States Radiopharmaceuticals Sales Market Share by Application (2012-2017)
Figure United States Radiopharmaceuticals Sales Market Share by Application (2012-2017)
Figure United States Radiopharmaceuticals Sales Market Share by Application in 2016
Table United States Radiopharmaceuticals Sales Growth Rate by Application (2012-2017)
Figure United States Radiopharmaceuticals Sales Growth Rate by Application (2012-2017)
Table Bracco Imaging Basic Information List
Table Bracco Imaging Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Bracco Imaging Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Bracco Imaging Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Bracco Imaging Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Bayer Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Bayer Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Bayer Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Mallinckrodt Basic Information List
Table Mallinckrodt Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Mallinckrodt Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Mallinckrodt Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Mallinckrodt Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Nordion Basic Information List
Table Nordion Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Nordion Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Nordion Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Nordion Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Triad Isotopes Basic Information List
Table Triad Isotopes Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Triad Isotopes Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Triad Isotopes Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Triad Isotopes Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Lantheus Basic Information List
Table Lantheus Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Lantheus Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Lantheus Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Lantheus Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table IBA Group Basic Information List
Table IBA Group Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure IBA Group Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure IBA Group Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure IBA Group Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure GE Healthcare Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure GE Healthcare Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure GE Healthcare Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table China Isotope & Radiation Basic Information List
Table China Isotope & Radiation Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure China Isotope & Radiation Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure China Isotope & Radiation Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure China Isotope & Radiation Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Jubilant Pharma Basic Information List
Table Jubilant Pharma Radiopharmaceuticals Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Jubilant Pharma Radiopharmaceuticals Sales Growth Rate (2012-2017)
Figure Jubilant Pharma Radiopharmaceuticals Sales Market Share in United States (2012-2017)
Figure Jubilant Pharma Radiopharmaceuticals Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Advanced Accelerator Applications Basic Information List
Table SIEMENS Basic Information List
Table Dongcheng Basic Information List
Table Navidea Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radiopharmaceuticals
Figure Manufacturing Process Analysis of Radiopharmaceuticals
Figure Radiopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Radiopharmaceuticals Major Players/Suppliers in 2016
Table Major Buyers of Radiopharmaceuticals
Table Distributors/Traders List
Figure United States Radiopharmaceuticals Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Radiopharmaceuticals Price (USD/Dose) Trend Forecast (2017-2022)
Table United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Type in 2022
Table United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Application in 2022
Table United States Radiopharmaceuticals Sales Volume (K Doses) Forecast by Region (2017-2022)
Table United States Radiopharmaceuticals Sales Volume Share Forecast by Region (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume Share Forecast by Region (2017-2022)
Figure United States Radiopharmaceuticals Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top